Article
Donor selection for allogeneic hematopoietic cell transplantation
3 Apr 2023
Abstract excerpt
BACKGROUND: In Germany, each year over 3000 patients with malignant and non-malignant hematologic and systemic diseases are treated by allo - geneic hematopoietic cell transplantation (HCT). Genetic donor-recipient disparities, especially those concerning variable human leukocyte antigens (HLA), mediate both an immunotherapeutic effect and the risk of damage to healthy tissues ("graft-versus-host disease"). The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
